JHIU
ATRS

Janus Henderson Investors US’s Antares Pharma, Inc. ATRS Stock Holding History

Janus Henderson Investors US’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-186,149
Closed -$434K – 1213
2016
Q4 		$434K Sell
186,149
-149,646
-45% -$285K ﹤0.01% 1123
2016
Q3 		$564K Buy
335,795
+238,383
+245% +$292K ﹤0.01% 1101
2016
Q2 		$102K Buy
+97,412
New +$94.1K ﹤0.01% 1183

Other funds holding ATRS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Janus Henderson Investors US's ATRS Position: Q1 2017 in Review

Janus Henderson Investors US sold out of Antares Pharma, Inc. (ATRS) in Q1 2017, closing a stake of 186,149 shares — an estimated $434K sold.

Janus Henderson Investors US first reported a position in ATRS in Q2 2016 and held it in 3 quarters. The position peaked at $564K in Q3 2016. 85 funds tracked by Wall St. Rank hold ATRS as of Q1 2017.

  • Janus Henderson Investors US reported no remaining Antares Pharma, Inc. position as of Q1 2017 after selling out during the quarter.
  • Janus Henderson Investors US sold 186,149 Antares Pharma, Inc. shares in Q1 2017, an estimated $434K.
  • Janus Henderson Investors US first reported a position in Antares Pharma, Inc. in Q2 2016 and held it in 3 quarters.
  • Janus Henderson Investors US's Antares Pharma, Inc. position peaked at $564K in Q3 2016.
  • 85 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.